Novation Pharmaceuticals Inc

Novation Pharmaceuticals Inc, based in Burnaby, BC, is dedicated to transforming the treatment landscape for neurodegenerative diseases, with a primary focus on amyotrophic lateral sclerosis (ALS). The company utilizes innovative technology, known as QUEST, to discover small molecules that modulate intracellular mRNA, aiming to develop effective therapies for serious conditions where no current cure or disease-modifying treatments exist.

In collaboration with esteemed research institutions, including the University of Montreal, Novation is advancing its drug discovery initiatives, particularly in the realm of neurodegeneration and cancer therapies. Through strategic partnerships and their proprietary drug discovery approach, Novation seeks to expedite the development of impactful therapeutics for patients in need.

Generated from the website